C07C 275/20
Of an unsaturated carbon skeleton
Official title: of an unsaturated carbon skeleton
C07C275/20 (Of an unsaturated carbon skeleton) appears on 467 US grants and 390 published applications in this corpus.
Search patents in C07C- Granted patents
- 467
- Published applications
- 390
- Assignees
- 260
- Inventors
- 1,389
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 6 | 0 |
| 1978 | 4 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 2 | 0 |
| 1986 | 5 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 6 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 8 | 0 |
| 1995 | 17 | 0 |
| 1996 | 24 | 0 |
| 1997 | 37 | 0 |
| 1998 | 14 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 11 | 2 |
| 2002 | 16 | 25 |
| 2003 | 15 | 19 |
| 2004 | 10 | 29 |
| 2005 | 10 | 21 |
| 2006 | 13 | 16 |
| 2007 | 10 | 12 |
| 2008 | 13 | 22 |
| 2009 | 10 | 22 |
| 2010 | 15 | 12 |
| 2011 | 13 | 15 |
| 2012 | 12 | 22 |
| 2013 | 13 | 19 |
| 2014 | 21 | 23 |
| 2015 | 15 | 8 |
| 2016 | 15 | 20 |
| 2017 | 16 | 22 |
| 2018 | 7 | 5 |
| 2019 | 8 | 15 |
| 2020 | 10 | 9 |
| 2021 | 4 | 20 |
| 2022 | 11 | 8 |
| 2023 | 6 | 10 |
| 2024 | 4 | 3 |
| 2025 | 7 | 8 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 18F-labeled triazole containing PSMA inhibitors14 Jul 2026US 12,679,812 B2Cornell University
- Calpain-2 inhibitor compounds and methods of treatment21 Apr 2026US 12,606,520 B2Western University of Health Sciences
- Cationic lipid compound, and preparation method therefor and use thereof10 Mar 2026US 12,569,449 B1Rongcan (Shanghai) Biotech Co., Ltd.
- Heterodimers of glutamic acid27 Jan 2026US 12,534,429 B2Molecular Insight Pharmaceuticals, Inc.
- Radioisotope labeled compound for imaging or treatment of prostate cancer2 Dec 2025US 12,486,294 B2Seoul National University R&Db Foundation
- Lipooligoureas, pharmaceutical composition, and lipooligoureas for use as medicament27 Aug 2026US 2026/0248748 A1Uniwersytet Warszawski
- Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors23 Jul 2026US 2026/0207636 A1
- Cationic lipids and preparation method thereof12 Mar 2026US 2026/0069542 A1RiboX Therapeutics HK Limited
- Composition for organ-specific delivery of nucleic acid23 Oct 2025US 2025/0325494 A1Themedium Therapeutics Co., Ltd.
- Lipid compound and use thereof12 Jun 2025US 2025/0188013 A1Themedium Therapeutics Co., Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Cancer cell targeting using nanoparticles115US 8,603,501 B2BIND Therapeutics, Inc. · 2013
- Cancer cell targeting using nanoparticles113US 8,603,499 B2BIND Therapeutics, Inc. · 2013
- Cancer cell targeting using nanoparticles113US 8,603,500 B2BIND Therapeutics, Inc. · 2013
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001